Malibu, California (PRWEB) April 30, 2012
Dr. Akikur Mohammad, Founder of Malibu Horizon, recognized by many as one of the top addiction treatment centers in California, and Assistant Clinical Professor of Psychiatry and the Behavioral Sciences at the University of Southern California, announced today that he and his team at Malibu Horizon were among the first addiction professionals to be given clearance to use Vivitrol to combat alcohol addiction and opiate addiction in the United States.
Dr. Mohammad has been on the forefront of addiction science for many years and countless patients at his alcohol rehab treatment facility Malibu Horizon have benefitted from his groundbreaking methods. Now that Vivitrol is receiving praise for its role in eliminating alcohol and opiate-related cravings, Dr. Mohammad is once again being recognized as a visionary in the addiction community based on his early use of the medication.
Dr. Mohammad said, “We immediately recognized that our patients suffering from severe cravings brought on by alcohol dependence and opiate addiction were getting virtually instant relief, which was eye-opening for us and lifesaving for them. As a result, we continued treating with Vivitrol and built what has become one of the country’s leading treatment protocol’s for patients struggling with alcohol and opiate dependence.” Mohammad added, “Vivitrol is injected monthly, not taken daily by mouth, so it's easier to stick to for patients and administer for professionals. Though patients can obtain buprenorphine at a pharmacy, they must go to clinics daily to get methadone. And, unlike methadone and buprenorphine, Vivitrol isn't an opioid but a long-acting form of naltrexone, which blocks opioids. It is a powerful non-narcotic solution and when there is concern about whether or not a patient will take their medication as prescribed, a monthly injection administered by their doctor is a perfect solution.”